GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Steminent Biotherapeutics Inc (ROCO:7729) » Definitions » Other Gross PPE

Steminent Biotherapeutics (ROCO:7729) Other Gross PPE : NT$79.39 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Steminent Biotherapeutics Other Gross PPE?

Steminent Biotherapeutics's Other Gross PPE for the quarter that ended in Jun. 2024 was NT$79.39 Mil.

Steminent Biotherapeutics's quarterly Other Gross PPE declined from Jun. 2023 (NT$83.21 Mil) to Dec. 2023 (NT$83.16 Mil) and declined from Dec. 2023 (NT$83.16 Mil) to Jun. 2024 (NT$79.39 Mil).

Steminent Biotherapeutics's annual Other Gross PPE increased from Dec. 2021 (NT$22.80 Mil) to Dec. 2022 (NT$58.87 Mil) and increased from Dec. 2022 (NT$58.87 Mil) to Dec. 2023 (NT$83.16 Mil).


Steminent Biotherapeutics Other Gross PPE Historical Data

The historical data trend for Steminent Biotherapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steminent Biotherapeutics Other Gross PPE Chart

Steminent Biotherapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Gross PPE
33.52 22.80 58.87 83.16

Steminent Biotherapeutics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Gross PPE Get a 7-Day Free Trial - 58.87 83.21 83.16 79.39

Steminent Biotherapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Steminent Biotherapeutics Business Description

Traded in Other Exchanges
N/A
Address
No.16,Wenhu Street, Neihu District, Taipei, TWN, 11445
Steminent Biotherapeutics Inc is a international stem cell biopharmaceutical company which has stable and efficient stem cell platform technology, aiming to develop live cell drugs to treat degenerative diseases as well as acute and life-threatening diseases. With its Stemchymal which is proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.

Steminent Biotherapeutics Headlines

No Headlines